Evofem Biosciences Inc (EVFM)
0.011
0.00 (0.00%)
USD |
OTCM |
Jun 21, 15:49
Evofem Biosciences Enterprise Value: 43.00M for June 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 20, 2024 | 43.00M |
| June 18, 2024 | 43.02M |
| June 17, 2024 | 43.09M |
| June 14, 2024 | 43.16M |
| June 13, 2024 | 43.16M |
| June 12, 2024 | 43.17M |
| June 11, 2024 | 43.13M |
| June 10, 2024 | 43.07M |
| June 07, 2024 | 43.12M |
| June 06, 2024 | 43.13M |
| June 05, 2024 | 43.16M |
| June 04, 2024 | 43.20M |
| June 03, 2024 | 43.15M |
| May 31, 2024 | 43.23M |
| May 30, 2024 | 43.28M |
| May 29, 2024 | 43.31M |
| May 28, 2024 | 43.25M |
| May 24, 2024 | 43.35M |
| May 23, 2024 | 43.22M |
| May 22, 2024 | 43.15M |
| May 21, 2024 | 43.22M |
| May 20, 2024 | 43.24M |
| May 17, 2024 | 43.25M |
| May 16, 2024 | 43.43M |
| May 15, 2024 | 43.31M |
| Date | Value |
|---|---|
| May 14, 2024 | 43.29M |
| May 13, 2024 | 43.16M |
| May 10, 2024 | 43.20M |
| May 09, 2024 | 43.13M |
| May 08, 2024 | 43.10M |
| May 07, 2024 | 43.01M |
| May 06, 2024 | 43.03M |
| May 03, 2024 | 42.94M |
| May 02, 2024 | 42.99M |
| May 01, 2024 | 43.03M |
| April 30, 2024 | 43.03M |
| April 29, 2024 | 43.07M |
| April 26, 2024 | 43.17M |
| April 25, 2024 | 43.04M |
| April 24, 2024 | 43.08M |
| April 23, 2024 | 42.98M |
| April 22, 2024 | 43.13M |
| April 19, 2024 | 43.10M |
| April 18, 2024 | 43.04M |
| April 17, 2024 | 43.02M |
| April 16, 2024 | 43.10M |
| April 15, 2024 | 43.08M |
| April 12, 2024 | 43.08M |
| April 11, 2024 | 43.13M |
| April 10, 2024 | 43.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
42.94M
Minimum
May 03 2024
425.84M
Maximum
Feb 17 2021
142.76M
Average
153.87M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.134M |
| Palatin Technologies Inc | 20.32M |
| iBio Inc | 26.84M |
| Theriva Biologics Inc | -11.07M |
| Oragenics Inc | 6.145M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.809M |
| Revenue (Quarterly) | 3.603M |
| Total Expenses (Quarterly) | 6.447M |
| EPS Diluted (Quarterly) | -0.16 |
| Gross Profit Margin (Quarterly) | 81.02% |
| Profit Margin (Quarterly) | -133.5% |
| Earnings Yield | -54.98K% |
| Normalized Earnings Yield | -56803.06 |